Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()

BACKGROUND: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Polyethylene glycol (PEG) has been suggested as the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World Allergy Organ J
Autori principali: Paoletti, Giovanni, Racca, Francesca, Piona, Alessandra, Melone, Giulio, Merigo, Morena, Puggioni, Francesca, Ferri, Sebastian, Azzolini, Elena, Lagioia, Michele, Lamacchia, Donatella, Cataldo, Giuseppe, Cecconi, Maurizio, Canonica, Giorgio Walter, Heffler, Enrico
Natura: Artigo
Lingua:Inglês
Pubblicazione: World Allergy Organization 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8030995/
https://ncbi.nlm.nih.gov/pubmed/33850601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100541
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi